Center for Mammalian Regulatory Genomics

人类基因组中所有功能序列的完整注释在其初始测序十年后仍然是一个主要挑战。这尤其与基因调控元件有关，其中许多元件位于远离其靶基因的地方，但在人类生物学中发挥着重要作用。近年来，主要利用培养的人类细胞对基因调控结构的注释取得了重大进展。然而，对小鼠的大规模研究以及在人类研究中发现的轶事例子表明，在哺乳动物发育过程中，存在大量具有非常有限的时间和组织特异性活性的基因调控序列。尽管这组调控序列在人类发育和疾病中至关重要，但仅限于细胞系或成人组织的方法可能会错过它们。为了填补这一空白，该U54应用程序的主要目标是利用现有的高通量数据生产管道，包括胚胎组织的ChlP-Seq、甲基c - seq和RNA-Seq基因组方法，生成发育活性基因调控序列的目录。由于处于相关发育阶段的人类胚胎有限，直接在人体组织上进行这类研究是不可行的。因此，我们将在本研究中利用实验室小鼠，这是一种广泛使用的动物模型，与人类具有相似的胚胎发育程序和基因调控结构。除了胚胎发育，我们的研究还将从出生后和成年小鼠中生成补充参考数据集，以更好地了解基因调控随时间的动态。此外，我们将利用已建立的转基因小鼠管道，通过深入的功能验证来评估鉴定的调控序列的生物学真实性。预计这些数据集的生成将填补哺乳动物基因组功能注释的主要空白，并有助于完成人类基因组基因调控序列的目录。

Complete annotation of all functional sequences in the human genome remains a major challenge a decade after its initial sequencing. This pertains in particular to gene regulatory elements, many of which are located far away from their target genes, but play fundamental roles in human biology. Significant progress towards annotation of the gene regulatory architecture has been made in recent years predominantly using cultured human cells. However, large-scale studies in mice, as well as anecdotal examples identified in human studies, have indicated the existence of large populations of gene regulatory sequences with very restricted temporal and tissue-specific activity during mammalian development. Despite their critical importance in human development and disease, this set of regulatory sequences will likely be missed by approaches restricted to cell lines or adult tissues. To fill this gap, the major objective for this U54 application is to generate catalogs of developmentally active gene regulatory sequences using existing high throughput data production pipelines for genomic approaches including ChlP-Seq, MethylC-Seq and RNA-Seq on embryonic tissues. Performing such studies directly on human tissues is not feasible due to limited availability of human embryos at relevant stages of development. We will therefore in this study exploit the laboratory mouse, a widely used animal model that shares a similar embryonic developmental program and gene regulatory architecture with humans. In addition to embryonic development, our studies will also generate a complementary reference dataset from postnatal and adult mice to better understand the dynamics of gene regulation over time. Furthermore, we will assess the biological authenticity of identified regulatory sequences by in-depth functional validation using an established transgenic mouse pipeline. It is anticipated that generation of these datasets will fill a major void in the functional annotation o a mammalian genome and help to complete the catalog of gene regulatory sequences in the human genome.